| Title |
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2022
|
| DOI | 10.1002/14651858.cd013444.pub2 |
| Pubmed ID | |
| Authors |
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, Michela Cinquini, Kerry Dwan |
X Demographics
The data shown below were collected from the profiles of 71 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 13 | 18% |
| United States | 5 | 7% |
| United Kingdom | 4 | 6% |
| Japan | 3 | 4% |
| Germany | 3 | 4% |
| Colombia | 3 | 4% |
| Brazil | 2 | 3% |
| Chile | 2 | 3% |
| Mexico | 2 | 3% |
| Other | 9 | 13% |
| Unknown | 25 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 56 | 79% |
| Practitioners (doctors, other healthcare professionals) | 10 | 14% |
| Scientists | 3 | 4% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 187 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 9% |
| Student > Master | 16 | 9% |
| Student > Ph. D. Student | 15 | 8% |
| Other | 11 | 6% |
| Student > Doctoral Student | 10 | 5% |
| Other | 20 | 11% |
| Unknown | 99 | 53% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 14% |
| Biochemistry, Genetics and Molecular Biology | 9 | 5% |
| Nursing and Health Professions | 8 | 4% |
| Neuroscience | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 23 | 12% |
| Unknown | 107 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2024.
All research outputs
#501,816
of 25,840,929 outputs
Outputs from Cochrane database of systematic reviews
#849
of 13,142 outputs
Outputs of similar age
#13,253
of 449,191 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 122 outputs
Altmetric has tracked 25,840,929 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,142 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.